Molecular subtyping can predict chemotherapy benefit in patients with colorectal canc
Molecular subtyping can help predict outcomes and chemotherapy benefit in patients with colorectal cancer, according to a presentation at the annual conference of the American Society of Clinical Oncology (ASCO).